期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

人eIF4A3真核表达载体构建及稳定表达细胞株筛选 被引量：2

Construction of human eIF4A3 eukaryotic expression plasmid and screening of stable cell line
原文传递
导出
摘要 目的构建人eIF4A3重组质粒载体,筛选高表达人eIF4A3的稳定细胞株。方法 RT-PCR克隆eIF4A3基因,将获得的基因片段分别连接到含有HA和c-myc标签的质粒载体上,转染HeLa细胞,经G418筛选获稳定表达细胞株,在体外翻译体系中进行体外翻译,通过免疫印迹鉴定eIF4A3的表达。结果成功构建人eIF4A3的真核表达载体,可在HeLa细胞中稳定表达,且能在体外翻译体系中翻译eIF4A3蛋白质。功能研究初步证明eIF4A3可以抑制荧光素酶报告基因的表达。结论获得了可稳定高表达人eIF4A3的HeLa细胞株及可用于体外翻译的真核表达载体。 Objective To construct the human eIF4A3 recombinant vector and screen the stable cell line over-expressing human eIF4A3.Methods Human eIF4A3 gene was cloned by RT-PCR.Gene fragments were linked to HA and c-myc labeled plasmid vectors to transfect HeLa cells.A stable cell line was generated by screening G418.In vitro translation was conducted in an in vitro translation system.Expression of eIF4A3 was identified by Western blotting.Results The human eIF4A3 eukaryotic expression vector was successfully constructed,which was stably expressed in HeLa cells and could translate the eIF4A3 protein in an in vitro translation system.Preliminary function study showed that eIF4A3 could inhibit the expression of luciferase reporter gene.Conclusion A HeLa cell line over-expressing human eIF4A3 we generated can be used as an eukaryotic expression vector in an in vitro translation system.
作者 李向云 徐祥 李秉煦 黄宏 徐云升
机构地区 温州医学院附属第一医院皮肤科 第三军医大学大坪医院野战外科研究所一室 创伤、烧伤与复合伤国家重点实验室
出处 《第三军医大学学报》 CAS CSCD 北大核心 2011年第18期1897-1899,共3页 Journal of Third Military Medical University
基金 国家自然科学基金(30972800)~~
关键词 真核起始因子4A3 稳定细胞株 体外翻译 eukaryotic initiation factor 4A3 stable cell line in vitro translation
分类号 R341 [医药卫生—基础医学] R394.33 [医药卫生—医学遗传学]
  • 相关文献

参考文献15

  • 1Tuteja N, Vashisht A A, Tuteja R. Translation initiation factor 4A: a prototype member of dead-box protein family [ J]. Physiol Mol Biol Plants, 2008, 14(1/2) : 101 - 107.
  • 2Shibuya T, Tange T O, Stroupe M E, et al. Mutational analysis of hu- man elF4AIII identifies regions necessary for exon junction complex formation and nonsense-mediated mRNA decay [ J]. RNA, 2006, 12 (3) : 360 - 374.
  • 3Dhalia R, Marinsek N, Reis C R, et al. The two elF4A helicases in Trypanosoma brucei are functionally distinct [ J ]. Nucleic Acids Res, 2006, 34 (9) : 2495 - 2507.
  • 4李进军,刘献志,万学峰,徐斌.mTOR/eIF4E信号通路在不同级别人脑胶质瘤组织中的表达及临床意义[J].第三军医大学学报,2010,32(23):2549-2551. 被引量：2
  • 5Koroleva O A, Calder G, Pendle A F, et al. Dynamic behavior of Arabidopsis elF4A-Ⅲ, putative core protein of exon junction complex: fast relocation to nucleolus and splicing speckles under hypoxia[ J]. Plant Cell, 2009, 21(5): 1592- 1606.
  • 6Nott A, Le-Hir H, Moore M J. Splicing enhances translation in mammalian cells : an additional function of the exon junction complex [ J ]. Genes Dev, 2004, 18(2) : 210 -222.
  • 7Bono F, Ebert J, Lorentzen E, et al. The crystal structure of the exon junction complex reveals how it maintains a stable grip on mRNA[ J ]. Cell, 2006, 126(4) : 713 -725.
  • 8Le-Hir H, Andersen G R. Structural insights into the exon junction complex [ J ]. Curt Opin Struct Biol, 2008, 18 ( 1 ) : 112 - 119.
  • 9Stroupe M E, Tange T O, Thomas D R, et al. The three-dimensional Arcitecture of the EJC core[J]. J Mol Biol, 2006, 360(4) : 743 -749.
  • 10Bercovich N, Levin M J, Clayton C, et al. Identification of core components of the exon junction complex in trypanosomes [ J ]. Mol Biochem Parasitol, 2009, 166(2) : 190 - 193.

二级参考文献11

  • 1吕红琼,周林静,王平,张华.真核翻译起始因子eIF4E与恶性肿瘤的研究进展[J].实用肿瘤学杂志,2007,21(1):88-91. 被引量：5
  • 2Nakada M, Nakada S, Demuth T, et al. Molecular targets of glioma invasion[J]. Cell Mol Life Sci, 2007, 64 (4) : 458 -478.
  • 3Franeceschi E, Tosoni A, Bartolini S, et al. Treatment options for recurrent glioblastoma: pitfalls and future trends [ J]. Expert Rev Anticancer Ther, 2009, 9(5): 613-619.
  • 4Heesom K J, Denton R M. Dissociation of the eukaryotic initiation factor4E/4E-BP1 complex involves phosphorylation of 4E-BP1 by an roTOR-associated kinase[ J ]. FEBS Lett, 1999, 457 (3) : 489 - 493.
  • 5Abraham R T, Wiederrecht G J. Immunopharmacology of rapamycin [J]. AnnuRevhnmunol, 1996, 14:483-510.
  • 6Kobayashi S, Kishimoto T, Kamata S, et al. Rapamycin, a specific inhibitor of the mammalian target of rapamycin, suppresses lymphangiogenesis and lymphatic metastasis[ J]. Cancer Sci, 2007, 98 (5) : 726-733.
  • 7Granville C A, Warfel N, Tsurutani J, et al. Identification of a highly effective rapamycin sehedule that markedly reduces the size, multiplicity, and phenotypic progression of tobacco carcinogen-induced murine lung tumorsIJ]. Clin Cancer Res, 2007, 13(7) : 2281 -2289.
  • 8黄嘉佳,林桐榆.mTOR通路及其抑制剂抗肿瘤的研究进展[J].癌症,2007,26(12):1397-1403. 被引量：21
  • 9赵林涛,卞修武,姜建勇,王斌,平轶芳,余时沧.下调CXCR4表达对胶质瘤干细胞侵袭能力和VEGF分泌量的影响[J].第三军医大学学报,2009,31(11):1049-1052. 被引量：4
  • 10郑鹏生,冀静.mTOR信号通路与肿瘤的研究进展[J].西安交通大学学报（医学版）,2010,31(1):1-9. 被引量：45

共引文献1

同被引文献22

  • 1潘保见,陈嘉薇,祝峰.宫颈鳞癌和癌前病变中eIF-4E表达及其与HPV16/18感染的关系[J].临床与实验病理学杂志,2007,23(5):528-531. 被引量：9
  • 2Suzuki C, Garces RG, Edmonds KA, et al. PDCD4 inhibits trans lation initiation by binding to elF4A using both its MA3 domains [J]. Proc Natl Acad Sci U S A,2008,105(9):3274-3279.
  • 3Ozes AR, Feoktistova K, Avanzino BC, et al. Duplex unwinding and ATPase activities of the DEAD-box helicase eIF4A are cou- pled by eIF4G and elF4B[J]. J Mol Biol,2011,412(4):674-687.
  • 4Zhou B, Phan V, Liu X, et al. Production of a monoclonal anti- body against the hRRM2 subunit of ribonucleotide reductase and immunohistochemistry study of human cancer tissues[J]. Hybri- doma (Larchmt) ,2006,25(5) :264-270.
  • 5Shveygert M,Kaiser C, Bradrick SS, et al. Regulation of eukary- otic initiation factor 4E (eIF4E) phosphorylation by mitogen-ac- tivated protein kinase occurs through modulation of Mnkl-eIF4G Interaction[J]. Mol Cell Biol,2010,30(21):5160-5167.
  • 6Meijer HA, Kong YW, Lu WT, et al. Translational repression and eIF4A2 activity are critical for microRNA-mediated gene regula- tion[J]. Science,2013,340(6128) :82-85.
  • 7Waters LC,Strong SL, Ferlemann E,et al. Structure of the tan- dem MA, 3 region of Pdcd4 protein and characterization of its interactions with eIF4A and eIF4G: molecular mechanisms of a tumor suppressor[J]. J Biol Chem, 2011,286(19) : 17270-17280.
  • 8Ravindar K, Reddy MS^ Lindqvist L, et al. Efficient synthetic approach to potent antiproliferative agent hippuristanol via Hg (11)-catalyzed spiroketalization. Org lett, 2010, 12:4420-4423.
  • 9Coleman L J, Peter M B, Teall T J, et al. Combined analysis of eIF4E and 4E-binding protein expression predicts breast cancer survival and estimates eIF4E activity. Br J Cancer, 2009, 100: 1393-1399.
  • 10NanF, Lu Q, Zhou J, et al. Alered expression of DACH1 and cyclin D1 in endometrial cancer. Cancer Biol Ther. 2009,8: 1534-1539.

引证文献2

二级引证文献2

第三军医大学学报
2011年 第18期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部